Works matching IS 15250016 AND DT 2008 AND VI 16 AND IP 3
Results: 29
The MDS1–EVI1 Gene Complex as a Retrovirus Integration Site: Impact on Behavior of Hematopoietic Cells and Implications for Gene Therapy.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 439, doi. 10.1038/sj.mt.6300372
- By:
- Publication type:
- Article
Targeted Migration of Mesenchymal Stem Cells Modified With CXCR4 Gene to Infarcted Myocardium Improves Cardiac Performance.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 571, doi. 10.1038/sj.mt.6300374
- By:
- Publication type:
- Article
Transient Immunomodulation Allows Repeated Injections of AAV1 and Correction of Muscular Dystrophy in Multiple Muscles.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 541, doi. 10.1038/sj.mt.6300377
- By:
- Publication type:
- Article
Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector–mediated GDNF Gene Transfer Into the Cochlea.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 474, doi. 10.1038/sj.mt.6300379
- By:
- Publication type:
- Article
Promoter-targeted siRNAs Induce Gene Silencing of Simian Immunodeficiency Virus (SIV) Infection In Vitro.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 565, doi. 10.1038/sj.mt.6300380
- By:
- Publication type:
- Article
Receptor-targeted Nanocomplexes optimized for Gene Transfer to Primary Vascular Cells and Explant Cultures of Rabbit Aorta.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 508, doi. 10.1038/sj.mt.6300381
- By:
- Publication type:
- Article
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 557, doi. 10.1038/sj.mt.6300382
- By:
- Publication type:
- Article
Inducible Packaging Cells for Large-scale Production of Lentiviral Vectors in Serum-free Suspension Culture.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 500, doi. 10.1038/sj.mt.6300383
- By:
- Publication type:
- Article
Corrigendum to “Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver”.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
CNS Delivery of Vectored Prion-specific Single-chain Antibodies Delays Disease Onset.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 481, doi. 10.1038/sj.mt.6300387
- By:
- Publication type:
- Article
Freeze-dried Tendon Allografts as Tissue-engineering Scaffolds for Gdf5 Gene Delivery.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 466, doi. 10.1038/sj.mt.6300395
- By:
- Publication type:
- Article
Development of Peptide-targeted Lipoplexes to CXCR4-expressing Rat Glioma Cells and Rat Proliferating Endothelial Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 516, doi. 10.1038/sj.mt.6300388
- By:
- Publication type:
- Article
Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 607, doi. 10.1038/sj.mt.6300390
- By:
- Publication type:
- Article
Engineering Human Tumor-specific Cytotoxic T Cells to Function in a Hypoxic Environment.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 599, doi. 10.1038/sj.mt.6300391
- By:
- Publication type:
- Article
Self-inactivating Gammaretroviral Vectors for Gene Therapy of X-linked Severe Combined Immunodeficiency.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 590, doi. 10.1038/sj.mt.6300393
- By:
- Publication type:
- Article
Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 525, doi. 10.1038/sj.mt.6300394
- By:
- Publication type:
- Article
Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 458, doi. 10.1038/sj.mt.6300389
- By:
- Publication type:
- Article
A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 618, doi. 10.1038/sj.mt.6300396
- By:
- Publication type:
- Article
Adeno-associated Virus of a Single-polarity DNA Genome Is Capable of Transduction In Vivo.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 494, doi. 10.1038/sj.mt.6300397
- By:
- Publication type:
- Article
A Rapid and Quantitative Assay for Measuring Neighboring Gene Activation by Vector Proviruses.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 534, doi. 10.1038/sj.mt.6300398
- By:
- Publication type:
- Article
Silencing of Episomal Transgene Expression in Liver by Plasmid Bacterial Backbone DNA Is Independent of CpG Methylation.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 548, doi. 10.1038/sj.mt.6300399
- By:
- Publication type:
- Article
Delta-24-RGD in Combination With RAD001 Induces Enhanced Anti-glioma Effect via Autophagic Cell Death.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 487, doi. 10.1038/sj.mt.6300400
- By:
- Publication type:
- Article
Genetic Modification of Neural Stem Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 450, doi. 10.1038/sj.mt.6300402
- By:
- Publication type:
- Article
A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 627, doi. 10.1038/sj.mt.6300403
- By:
- Publication type:
- Article
Sleeping Beauty Transposon mediated Engineering of Human Primary T Cells for Therapy of CD19<sup>+</sup> Lymphoid Malignancies.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 580, doi. 10.1038/sj.mt.6300404
- By:
- Publication type:
- Article
En Route to Ethical Recommendations for Gene Transfer Clinical Trials.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Research Highlights.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 431, doi. 10.1038/mt.2008.21
- Publication type:
- Article
In This Issue.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 3, p. 430, doi. 10.1038/mt.2008.27
- Publication type:
- Article
NIH Recombinant DNA Advisory Committee Continues to Ponder Adverse Event Associated With AAV Gene Therapy Trial.
- Published in:
- 2008
- By:
- Publication type:
- Editorial